ClinicalTrials.gg
Not yet recruitingNCT07657559ELPPUpdated Jun 18, 2026

RCT - Suprapatellar Approach Versus Lateral Parapatellar Approach in Tibial Shaft Fracture

An interventional study of suprapatellar approach and extra-articular lateral parapatellar approach in Tibial Shaft Fracture and Intramedullary Nail, sponsored by Queen Savang Vadhana Memorial Hospital, Thailand. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by Queen Savang Vadhana Memorial Hospital, Thailand · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study aims to compare 2 surgical techniques for tibial shaft nailing (suprapatellar approach vs extra-articular lateral parapatellar approach). following peri-operative and postoperative outcomes

Read the detailed description

This is a randomized controlled trial study, compared extra-articular lateral parapatellar approach with suprapatellar approach in tibial shaft nailing. peri-operative data are operative time, blood loss, fluoroscopy time, hospital stay. post-operative outcomes include Lysholm Knee Score, VAS-knee, range of motion. these outcomes are following postoperative day 1, 2 weeks, 6 weeks, 3 months and 6 months.

02

Conditions studied

  • Tibial Shaft Fracture
  • Intramedullary Nail

Keywords

  • suprapatellar approach
  • extra-articular lateral parapatellar approach
  • intramedullary nailing
  • tibial shaft fracture
03

In context

Lead sponsor

Queen Savang Vadhana Memorial Hospital, Thailand is the lead sponsor of 30 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18-60 years
  • tibial shaft fractures

Exclusion criteria

Exclusion Criteria:

  • pervious knee injury
  • open fracture at least Gustilo grade II
  • ipsilateral femur and ankle fractures
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    suprapatellar approach

    Procedure: suprapatellar approach

  • Experimental
    extra-articular lateral parapatellar approach

    Procedure: extra-articular lateral parapatellar approach

Interventions

  • Proceduresuprapatellar approach

    semi-extended position longitudinal incision 2 cm. above patella nail insertion procedure under patellofemoral joint

  • Procedureextra-articular lateral parapatellar approach

    semi-extended position longitudinal incision 4-5 cm., lateral to patellar tendon nail insertion procedure

06

What researchers measure

Primary outcomes

  1. Lysholm Knee Score

    Time frame: 6 months

Secondary outcomes

  1. operative time

    Time frame: operation

  2. VAS score of knee

    Time frame: POD 1, 2 weeks, 6 weeks, 3 months, 6 months

  3. range of motion

    knee

    Time frame: POD 1, 2 weeks, 6 weeks, 3 months, 6 months

  4. intraoperative blood loss

    Time frame: operation

  5. fluoroscopy time

    Time frame: operation

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — data was save in form of Microsoft excel spreadsheet and SPSS file

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Aug 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2026
First posted
Jun 18, 2026
StartEst.
Aug 1, 2026
Primary completionEst.
Aug 1, 2026
CompletionEst.
Aug 31, 2028
Last update
Jun 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07657559
Lead sponsor
Queen Savang Vadhana Memorial Hospital, Thailand
Responsible party
Sponsor
First posted
Jun 18, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Aug 1, 2026 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Jun 18, 2026

Study contacts

Tiwat Wongkasemjit M.D., Resident
Contact
toytiwat@gmail.com
+66893146833

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion